Senores Pharmaceuticals Limited (BOM:544319)
898.70
-1.45 (-0.16%)
At close: Apr 30, 2026
Senores Pharmaceuticals Market Cap
Senores Pharmaceuticals has a market cap or net worth of 41.41 billion as of May 1, 2026. Its market cap has increased by 71.95% in one year.
Market Cap
41.41B
Enterprise Value
42.00B
Revenue
5.53B
Ranking
n/a
PE Ratio
40.76
Stock Price
898.70
Market Cap Chart
Since December 30, 2024, Senores Pharmaceuticals's market cap has increased from 25.65B to 41.41B, an increase of 61.42%. That is a compound annual growth rate of 43.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 41.41B | 9.37% |
| Dec 31, 2025 | 37.87B | 44.60% |
| Dec 31, 2024 | 26.19B | 2.07% |
| Dec 30, 2024 | 25.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CORONA Remedies | 103.07B |
| Viyash Scientific | 91.68B |
| Procter & Gamble Health | 85.09B |
| Sanofi India | 79.10B |
| FDC Limited | 59.40B |
| Gufic Biosciences | 29.04B |
| Bliss GVS Pharma | 28.49B |
| Novartis India | 26.00B |